Yoshimaru Tetsuro, Suzuki Yoshihiro, Inoue Toshio, Ra Chisei
Division of Molecular Cell Immunology and Allergology, Advanced Medical Research Center, Nihon University Graduate School of Medical Science, 30-1 Oyaguchikami-cho Itabashi-ku, Tokyo 173-8610, Japan.
Mol Immunol. 2009 Apr;46(7):1267-77. doi: 10.1016/j.molimm.2008.11.011. Epub 2009 Jan 6.
Store-operated Ca(2+) channels (SOCs) are considered to be the principal route of Ca(2+) influx in non-excitable cells. We have previously shown that in mast cells IgE+antigen (Ag) induces a dihydropyridine (DHP)-sensitive Ca(2+) influx independently of Ca(2+) store depletion. Since the DHP receptor is the alpha subunit of L-type Ca(2+) channels (LTCCs), we examined the possible role of LTCCs in mast cell activation. Mast cells exhibited substantial expression of the alpha(1C) (Ca(V)1.2) subunit mRNA and protein on their cell surface. IgE+Ag-induced Ca(2+) influx was substantially reduced by the LTCC inhibitor nifedipine, and enhanced by the LTCC activator (S)-BayK8644, whereas these agents had minimal effects on thapsigargin (TG)-induced Ca(2+) influx. These LTCC-modulating agents regulated IgE+Ag-induced cell activation but not TG-induced cell activation. Inhibition of SOCs by 2-aminoethoxydiphenyl borate reduced both degranulation and production of cytokines, including interleukin-13 and tumor necrosis factor-alpha, whereas LTCC modulation reciprocally regulated degranulation and cytokine production. IgE+Ag, but not TG, induced substantial plasma membrane depolarization, which stimulated a DHP-sensitive Ca(2+) response. Moreover, IgE+Ag-, but not TG-induced mitochondrial Ca(2+) increase was regulated by LTCC modulators. Finally, gene silencing analyses using small interfering RNA revealed that the alpha(1C) (Ca(V)1.2) LTCC mediated the pharmacological effects of the LTCC-modulating agents. These results demonstrate that mast cells express LTCCs, which becomes activated by membrane depolarization to regulate cytosolic and mitochondrial Ca(2+), thereby controlling mast cell activation in a distinct manner from SOCs.
储存性钙通道(SOCs)被认为是非兴奋性细胞中钙离子内流的主要途径。我们之前已经表明,在肥大细胞中,IgE + 抗原(Ag)可诱导二氢吡啶(DHP)敏感的钙离子内流,且不依赖于钙离子储存耗竭。由于DHP受体是L型钙通道(LTCCs)的α亚基,我们研究了LTCCs在肥大细胞活化中的可能作用。肥大细胞在其细胞表面呈现出α(1C)(Ca(V)1.2)亚基mRNA和蛋白的大量表达。LTCC抑制剂硝苯地平可显著降低IgE + Ag诱导的钙离子内流,而LTCC激活剂(S)-BayK8644则可增强该内流,而这些药物对毒胡萝卜素(TG)诱导的钙离子内流影响极小。这些LTCC调节药物可调节IgE + Ag诱导的细胞活化,但不调节TG诱导的细胞活化。2-氨基乙氧基二苯硼酸对SOCs的抑制作用降低了脱颗粒以及包括白细胞介素-13和肿瘤坏死因子-α在内的细胞因子的产生,而LTCC调节则相反地调节脱颗粒和细胞因子的产生。IgE + Ag而非TG可诱导显著的质膜去极化,这刺激了DHP敏感的钙离子反应。此外,LTCC调节剂可调节IgE + Ag而非TG诱导的线粒体钙离子增加。最后,使用小干扰RNA进行的基因沉默分析表明,α(1C)(Ca(V)1.2)LTCC介导了LTCC调节药物的药理作用。这些结果表明,肥大细胞表达LTCCs,其通过膜去极化而被激活,以调节细胞质和线粒体钙离子,从而以与SOCs不同的方式控制肥大细胞活化。